Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Sunshine Biopharma (SBFM) Other Gross PP&E Adjustments (2019 - 2025)

Sunshine Biopharma's Other Gross PP&E Adjustments history spans 5 years, with the latest figure at $291403.0 for Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments rose 645.2% year-over-year to $291403.0; the TTM value through Dec 2025 reached $291403.0, up 645.2%, while the annual FY2025 figure was $291403.0, 645.2% up from the prior year.
  • Other Gross PP&E Adjustments reached $291403.0 in Q4 2025 per SBFM's latest filing, up from $240067.0 in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $291403.0 in Q4 2025 to a low of -$728129.0 in Q1 2023.
  • Average Other Gross PP&E Adjustments over 4 years is -$273702.2, with a median of -$282354.0 recorded in 2022.
  • Peak YoY movement for Other Gross PP&E Adjustments: rose 17.56% in 2024, then skyrocketed 645.2% in 2025.
  • A 4-year view of Other Gross PP&E Adjustments shows it stood at -$282354.0 in 2022, then surged by 67.8% to -$90915.0 in 2023, then skyrocketed by 41.21% to -$53449.0 in 2024, then surged by 645.2% to $291403.0 in 2025.
  • Per Business Quant, the three most recent readings for SBFM's Other Gross PP&E Adjustments are $291403.0 (Q4 2025), $240067.0 (Q3 2025), and $158163.0 (Q2 2025).